PPBT Stock Summary and Trading Ideas (Purple Biotech Ltd. - American Depositary Shares | NASDAQ:PPBT)

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Purple Biotech Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol PPBT.

As of June 18, 2026, PPBT stock price declined to $1.70 with 26,175 million shares trading.

PPBT has a beta of 1.07, meaning it tends to be more sensitive to market movements. PPBT has a correlation of 0.01 to the broad based SPY ETF.

PPBT has a market cap of $1.58 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, PPBT traded as high as $360.00 and as low as $1.42.

PPBT has underperformed the market in the last year with a price return of -93.0% while the SPY ETF gained +26.9%. PPBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -55.4% and -45.0%, respectively, while the SPY returned +13.5% and -1.1%, respectively.

PPBT support price is $1.61 and resistance is $1.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PPBT shares will trade within this expected range on the day.